The North America albinism drug market is supported by advanced healthcare infrastructure, growing awareness of rare genetic disorders, and continued research into potential therapeutic options. Researchers are investigating approaches such as melanin-enhancing compounds and other targeted therapies, while established specialty care networks help address the visual and dermatological needs of...